AMPLIDYNE INC
NT 10-Q, 1999-11-15
ELECTRONIC COMPONENTS, NEC
Previous: ALLAIRE CORP, 10-Q, 1999-11-15
Next: CORNELL CORRECTIONS INC, 10-Q, 1999-11-15




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12B-25
                         COMMISSION FILE NUMBER-0-21931
                           NOTIFICATION OF LATE FILING

(CHECK ONE)
 [ ] FORM 10-K AND FORM 10-KSB  [ ] FORM 20-F [ ] FORM 11-K [X] FORM 10-Q AND
     FORM 10-QSB [ ] FORM N-SAR

                           FOR PERIOD ENDED SEPTEMBER 30, 1999
                           __ TRANSITION REPORT ON FORM 10-K AND FORM 10-KSB
                           __ TRANSITION REPORT ON FORM  20-F
                           __ TRANSITION REPORT ON FORM 11-K
                           __ TRANSITION REPORT ON FORM 10-Q AND FORM 10-QSB
                           __ TRANSITION REPORT ON FORM N-SAR
                           FOR THE TRANSITION PERIOD ENDED:

             READ INSTRUCTIONS (ON BACK PAGE) BEFORE PREPARING FORM.
                              PLEASE PRINT OR TYPE.
    NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
                   VERIFIED ANY INFORMATION CONTAINED HEREIN.

         IF THE  NOTIFICATION  RELATES TO A PORTION OF THE FILING CHECKED ABOVE,
IDENTIFY THE ITEM(S) TO WHICH THE NOTIFICATION RELATES:

PART I--REGISTRANT INFORMATION

Full Name of Registrant:            AMPLIDYNE, INC.
- --------------------------------------------------------------------------------

Former Name of Registrant:
- --------------------------------------------------------------------------------

Address of Principal Executive Office (Street and Number):

                 59 LAGRANGE STREET, RARITAN, NEW JERSEY 08869
- --------------------------------------------------------------------------------

<PAGE>
PART II--RULES 12B-25(B) AND (C)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant  seeks relief pursuant to Rule 12b-25b,  the following should
be completed. (Check box if appropriate):

[X] (a)  The reasons  described  in  reasonable  detail in Part III of this form
         could not be eliminated without unreasonable effort or expense;

[X] (b)  The subject annual report,  semi-annual  report,  transition  report on
         Forms 10-K,  10-KSB,  Form 20-F,  11-K, Form N-SAR, or portion thereof,
         will be filed on or before the  fifteenth  calendar day  following  the
         prescribed  due date;  or the subject  quarterly  report or  transition
         report on Forms 10-Q,  10-QSB,  or portion  thereof will be filed on or
         before the fifth calendar day following the prescribed due date; and

[ ] (c)  The accountant's  statement or other exhibit required by Rule 12b-25(c)
         has been attached if applicable.

PART III--NARRATIVE

State below in reasonable detail the reasons why the Forms 10-K,  10-KSB,  20-F,
11-K, 10-Q,10-QSB, N-SAR, or the transition report or portion thereof, could not
be filed within the prescribed time period. (ATTACH EXTRA SHEETS IF NEEDED)

         The Company has not been able to compile the requisite  financial  data
and other narrative  information  necessary to enable it to have sufficient time
to complete the Company's  Quarterly Report on Form 10-QSB by November 14, 1999,
the required filing date, without unreasonable effort and expense.

PART IV--OTHER INFORMATION

(1)      Name and  telephone  number  of  person  to  contact  in regard to this
         notification

         Devendar S. Bains            (908)             253-6870
         --------------------      ----------      ---------------------
         (NAME)                    (AREA CODE)     (TELEPHONE NUMBER)

(2)      Have all other periodic  reports  required under Section 13 or 15(d) of
         the  Securities  Exchange  Act of 1934 or Section 30 of the  Investment
         Company Act of 1940 during the preceding 12 months (or for such shorter
         period that the  registrant  was  required to file such  reports)  been
         filed? If answer is no, identify report(s). [X] Yes  [ ] No

(3)      Is it anticipated that any significant  change in results of operations
         from  the  corresponding  period  for  the  last  fiscal  year  will be
         reflected  by the  earnings  statements  to be  included in the subject
         report or portion thereof?
                                                     [ ] Yes  [X] No

         If  so,  attach  an  explanation  of  the  anticipated   change,   both
narratively and  quantitatively,  and, if  appropriate,  state the reasons why a
reasonable estimate of the results cannot be made.
<PAGE>

                                 AMPLIDYNE, INC.
                  --------------------------------------------
                  (Name of Registrant as Specified In Charter)


has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereto duly authorized

Dated:  November 15, 1999                   AMPLIDYNE, INC.



                                            By: /s/ DEVENDAR S. BAINS
                                               ---------------------------------
                                                    Devendar S. Bains,
                                                    Chief Executive Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION

         INTENTION   MISSTATEMENTS  OR  OMISSIONS  OF  FACT  CONSTITUTE  FEDERAL
CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).

                              GENERAL INSTRUCTIONS

1.       This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
Rules and Regulations under the Securities Exchange Act of 1934.

2.       One  signed  original  and  four  conformed  copies  of this  form  and
amendments  thereto must be completed and filed with the Securities and Exchange
Commission,  Washington,  D.C. 20549, in accordance with Rule 0-3 of the General
Rules and Regulations under the Act. The information  contained in or filed with
the form will be made a matter of public record in the Commission files.

3.       A manually  signed  copy of the form and  amendments  thereto  shall be
filed with each national securities exchange on which any class of securities of
the registrant is registered.

4.       Amendments to the  notifications  must also be filed on form 12b-25 but
need not restate information that has been correctly  furnished.  The form shall
be clearly identified as an amendment notification.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission